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Expression of a foreign gene in cerebellar Purkinje cells in 
vivo is a powerful method for exploring pathophysiology of the 
cerebellum. Although using developmental engineering many 
gene-modified mice have been generated, this approach is 
time-consuming and requires a lot of effort for crossing 
different lines of mice, genotyping and maintenance of animals. 
If a gene of interest can be transferred to and efficiently 
expressed in Purkinje cells of developing and mature animals, 
it saves much time, effort and money. Recent advance in viral 
vectors has markedly contributed to selective and efficient 
gene transfer to Purkinje cells in vivo. There are two 
approaches for selective gene expression in Purkinje cells: one 
is to take an advantage of viral tropism for Purkinje cells, 
which includes the tropism of adeno-associated virus and the 
vesicular stomatitis virus glycoprotein (VSV-G)-pseudotyped 
lentivirus. Another method, which might be used in combination 
with the first one, is utilization of a Purkinje-cell-specific 
promoter. Focusing mainly on these points, recent progress in 










The cerebellum plays important roles in coordinated movement, 
motor learning and vestibular function, and cerebellar damage 
results in impaired body balance and disturbance in gait and 
posture. A major input to the cerebellar cortex is mossy fibers 
that originate from thalamus, brain stem and spinal cord, and 
make excitatory synapses with cerebellar granule cells. The 
activity of granule cells is transferred through their axons, 
called parallel fibers, to Purkinje cells. A Purkinje cell has 
ramified dendrites studded with hundred thousands of spines, 
on which parallel fibers make excitatory synapses. Parallel 
fiber-Purkinje cell spine synapses are tightly covered with 
processes of Bergmann glia so as to quickly take up glutamate 
released from parallel fiber terminals and thereby to prevent 
the glutamate from spilling over and activating the adjacent 
synapses. Another input to the cerebellar cortex is climbing 
fibers that originate from neurons in the inferior olivary 
nucleus and make excitatory synapses with Purkinje cells as well 
as neurons in the deep cerebellar nuclei. Purkinje cells, the 
sole source of output from the cerebellar cortex, exert 
inhibitory actions on the neurons of the deep cerebellar nuclei. 
The excitatory activity of granule cells and Purkinje cells is 
modulated by 3 types of inhibitory interneurons, Golgi cells, 
stellate cells and basket cells.  
     It is well known that long-term depression of synaptic 
transmission (LTD) at parallel fiber - Purkinje cell synapses 
can be induced upon conjunctive stimulation of parallel fibers 
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and climbing fibers, which is thought to provide a cellular 
basis for motor learning. Purkinje cells are thus key elements 
of higher brain function in the cerebellum as well as in 
maintaining the regulation of coordinated movement and body 
balance. These important cells are easily damaged by toxins, 
ischemia, infection or inherited disorders.1 Accordingly, 
efficient and targeted expression of foreign genes in Purkinje 
cells is a powerful method for basic and translational research, 
such as studies of synaptic plasticity or gene therapy for 
diseases affecting Purkinje cells, including several major 
types of spinocerebellar ataxia. Gene transfer to Parkinje 
cells might not appear to be a big challenge, because the surface 
area of Purkinje cells is much larger than that of other cortical 
cells. However, it is indeed a challenge, partly because the 
well-developed dendrites occupying most of the surface area of 
Purkinje cells are tightly wrapped with the radial processes 
of Bergmann glia. Considerable effort has been devoted to 
transduce Purkinje cells using various types of viral vectors. 
In this mini review, I summarize the recent progress in 
viral-vector-mediated gene transfer into Purkinje cells in 
vivo. 
 
Transduction of Purkinje cells using adenoviral vectors 
Early adenoviral vectors were associated with toxicity that led 
to an inability to achieve stable transgene expression. 
Thereafter, the vectors were substantially altered to improve 
the stability of transgene expression by eliminating the 
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expression of viral proteins that cause the immune response. 
Consequently, many studies have succeeded in expressing foreign 
genes efficiently in neurons of various brain regions, 
including the striatum, hippocampus and cerebral cortex.2-4 In 
line with this, the potential of adenoviral vectors to transduce 
Purkinje cells was tested. Adenoviral vectors expressing LacZ 
under the control of the Purkinje-cell-specific L7 promoter 
demonstrated Purkinje-cell-specific transduction.5 However, 
the efficiency was very low: in that study, only two transduced 
Purkinje cells in one section (285 μm x 285 μm) were presented. 
The low tranduction efficiency of Purkinje cells in vivo using 
adenoviral vectors was confirmed by a different group,6 in which 
virus-mediated LacZ expression was detected in very few 
Purkinje cells upon cortical injection, and the majority of 
cells transduced were Bergmann glia. Since we also observed 
essentially the same expression pattern: preferential 
transduction of Bergmann glia when adenoviral vectors were 
injected into the cerebellar cortex (unpublished data), we gave 
up using adenoviral vectors for gene transfer to Purkinje cells 
in vivo. Ozawa’s group took advantage of the fact that 
adenoviral vectors preferentially infect Bergmann glia.7 
Native Bergmann glia express only GluR1 and GluR4 subunits of 
AMPA-type glutamate receptors (AMPA receptors), and lack GluR2, 
which confers Ca2+-permeability on AMPA receptors of Bergmann 
glia. Using adenoviral vectors, Ozawa’s group succeeded in 
expressing exogenous GluR2 subunit selectively in Bergmann glia 
and thereby replacing the Ca2+-permeable AMPA receptors with 
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Ca2+-impermeable ones. Thus, the adenoviral vectors currently 
used are effective for selective gene transfer to Bergmann glia, 
but have substantially limited potential for transducing 
Purkinje cells in vivo, although Purkinje cells in culture could 
be transduced efficiently using these vectors.5,8  
 
Transduction of Purkinje cells using herpes simplex viral 
vectors 
A unique feature of herpes simplex virus 1 (HSV-1) vector is 
long neuronal transport through axons using microtubule motors 
of the infected neurons.9,10 Because HSV-1 is a neurotropic virus 
that causes encephalitis when introduced into the brain, much 
effort was made to modify HSV-1 so that the virus could be safely 
used as a gene transfer vector.11 The defective helper-dependent 
amplicon vector is a toxicity-attenuated mutant of HSV-1 that 
lacks all portions of the genome except for an origin of DNA 
replication and DNA packaging signal sequences.12 Agdo et al.13 
used HSV-1 amplicon vectors carrying the lacZ gene to transduce 
Purkinje cells, and showed that injection of HSV-1 vectors into 
the inferior olivary nucleus, rather than into the cerebellar 
cortex, led to efficient transduction of Purkinje cells. The 
vector transport from the inferior olivary complex to the 
cerebellar cortex is discussed in a later section. The 
HSV-1-vector-mediated expression of the lacZ gene within 
Purkinje cells was persistent and was maintained at the same 
level for at least 40 days with no significant signs of toxicity 
or inflammation. However, viral injection into the inferior 
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olivary nucleus located in the deep medulla has potential to 
cause significant, and in the worst case, life-threatening 
damage to the medulla, which could be a big problem in clinical 
application. As an alternative way, it is intriguing to test 
whether the injection of HSV-1 vectors into the deep cerebellar 
nuclei could cause efficient transduction of Purkinje cells. 
 
Transduction of Purkinje cells using adeno-associated viral 
vectors 
Recombinant adeno-associated virus (rAAV) is a promising gene 
therapy vector because wild-type adeno-associated virus is 
nonpathogenic, and expression of transgenes is sustained 
without integration of the viral genome into the host genome: 
integration of proviruses into a host chromosome could cause 
insertional mutagenesis associated with severe side effects. 
One major limitation of rAAV is the insert capacity, which 
primarily depends on the genome size of wild-type AAV.14 
Wild-type AAV genome with the size of 4.7 kb is replaced by a 
transgene cassette consisting of a promoter plus transgene, 
which should be theoretically less than 4.7 kb; otherwise, virus 
production is significantly affected due to impaired packaging. 
Thus, from the point of packaging capacity, the ideal size for 
rAAV-mediated-gene transfer is thought to be 4 kb or less, 
although it differs depending on the size of the promoter 
accommodated. Currently, at least 10 serotypes of AAV have been 
used to engineer recombinant viral vectors.15,16 As different 
AAV serotypes enter cells via distinct cell surface receptors, 
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the tropism of different serotypes for neurons has been tested. 
rAAV2 is the serotype most widely used for gene transfer to 
neuronal cells because it transduces mostly neurons.16-19 rAAV1 
and rAAV5 have been shown to have higher transduction efficiency 
and higher levels of transgene expression than rAAV2 in various 
brain regions.20-22 rAAV-mediated transduction of adult Purkinje 
cells in vivo has been shown by two groups.23-25 Low’s group showed 
transduction of thousands of Purkinje cells upon cortical 
injection of rAAV2 vectors,24 while Davidson’s group achieved 
comparable or even better results by injecting rAAV523 or rAAV125 
vectors into the cerebellar cortex. We have also succeeded in 
transducing adult Purkinje cells in vivo by cortical injection 
of rAAV2 vectors expressing GFP (Fig. 1). On the other hand, 
Sena-Esteves’s group showed efficient transduction of newborn 
mouse Purkinje cells by rAAV1, rAAV2 or rAAV8 after viral 
injection into cerebral lateral ventricle.26 Among the 
serotypes tested, rAAV8 was found to cause most efficient 
transduction as well as the highest intensity of gene expression 
in Purkinje cells. Thus, in addition to developing neurons, 
rAAV8 may be promising for gene delivery to mature Purkinje 
cells. 
 
Transduction of Purkinje cells using lentiviral vectors 
Retroviruses have a single-stranded RNA genome. The genome RNA 
is replicated to a double-stranded DNA intermediate that is 
integrated in the nuclear chromosome of the infected cell. The 
retroviridae family is divided into three groups: the 
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oncoviridae, the lentiviridae and the spumaviridae. Because a 
double-stranded DNA intermediate of retroviruses of the 
oncoviridae cannot be transferred to the nucleus except during 
the period of cell division, the retroviruses cannot transduce 
post-mitotic cells, and therefore have limited utility in the 
brain.14 On the other hand, lentiviridae retroviruses can pass 
through the pore of the nuclear membrane and transduce 
post-mitotic neurons, a feature that distinguishes them from 
oncoretroviridae. Lentiviridae include human immunodeficiency 
virus (HIV)-1, HIV-2, feline immunodeficiency virus (FIV) and 
simian immunodeficiency virus. Like rAAV vectors, lentiviral 
vectors have strict limitations of the insert capacity, but 
their capacity is almost twice (~ 8 kb) as large as that of AAV 
vectors (~ 4.7 kb).  
Using FIV-derived vectors, Alisky et al. showed efficient 
transduction of Purkinje cells as well as stellate cells and 
Golgi cells in vivo.23 We used HIV-1-derived lentiviral vectors 
for the transduction of Purkinje cells. The original HIV 
selectively infects CD4-positive cells such as T cells and 
macrophages. In order to gain broader tropism than that of the 
wild-type virus, the native envelope glycoprotein of 
HIV-derived lentiviral vectors is replaced with that of 
vesicular stomatitis virus (VSV-G), a method called 
pseudotyping. As VSV-G binds to phosphatidylserine of the 
plasma membrane, VSV-G-pseudotyped lentiviral vectors are 
expected to infect all types of cells: however, they did not 
transduce cerebellar granule cells when injected into the 
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cerebellar cortex.27 Moreover, we experienced that 
lentiviral-tropism was significantly influenced by the period 
of cultivation of HEK293FT cells after transfection of the cells 
with viral plasmids.28 Lentiviruses are harvested 2 days (40 
h) after transfection of HEK293FT cells (1st harvest). As the 
HEK293FT cells look healthy and adhere tightly to the culture 
dish (Fig. 2A), additional virus can be obtained again the next 
day (64 h) by further incubating the cells after the addition 
of fresh medium (2nd harvest). The HEK293FT cells are 
substantially damaged at this time(Fig. 2C). In a previously 
published protocol for lentiviral production,29 the authors 
proposed pooling the virus-containing supernatant from the 1st 
and 2nd harvests, presumably to double the viral vectors 
obtained. Initially, we used lentiviral vectors concentrated 
from the 1st harvest for the transduction of cerebellar cells, 
resulting in Purkinje-cell-preferential transduction (Fig. 
2B). Thereafter, we began to use lentivirus solution prepared 
from the 2nd harvest, which unexpectedly resulted in 
Bergmann-glia-preferential transduction (Fig. 2D). We then 
attempted to identifying factor(s) that substantially 
decreased the lentiviral tropism for Purkinje cells, and found 
that the pH of the medium used to cultivate HEK293FT cells is 
critical for the viral tropism of Purkinje cells.28 Although 
the mechanism underlying this phenomenon has not been fully 
clarified, our current hypothesis is that modification of VSV-G 
by a protease, which is probably released into the culture 
medium from lysed HEK293T cells, affects the viral tropism for 
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Purkinje cells.  
     Another factor that critically affects lentiviral tropism 
for Purkinje cells is variations of the lot of fetal bovine serum 
(FBS) preparations used to supplement the culture media.30 We 
used 8 different serum lots (S1 – S8) to supplement the culture 
medium, generated lentiviruses and injected the resultant 8 
viral solutions into mouse cerebellar cortices. Lentiviral 
vectors produced using FBS S1, S2 and S3 showed 
neuron-preferential transduction: those produced using S1 
transduced stellate cells and basket cells in addition to 
Purkinje cells, while those produced using S2 or S3 selectively 
transduced Purkinje cells.30 In contrast, viral vectors 
produced using other lots of FBS resulted in glia-preferential 
or non-selective transduction. Representative examples of the 
transduction patterns of cerebellar cells are shown in Fig. 3. 
It should be noted that the titers of the 8 lentiviral solutions 
that were determined using HeLa cells were almost identical. 
Further studies will be needed to elucidate the mechanisms 
underlying the pH- and serum-quality-dependent differences of 
the tropism of VSV-G-pseudotyped lentiviral vectors for 
Purkinje cells.  
 
Relationship between injection sites and transduced regions in 
the brain 
In addition to the transduction of cerebellar cortical cells, 
adenoviral vectors injected into the cerebellar cortex cause 
transduction of neurons in the pontine nuclei and inferior 
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olivary nuclei.6 This is mediated by the retrograde axonal 
transport of the viral genome through mossy fibers and climbing 
fibers projecting to the cerebellar cortex, as shown in figure 
4A. Unlike injection of adenoviral vectors, injection of HSV-1 
vectors into the cerebellar cortex does not transduce cortical 
cells, including Purkinje cells, efficiently. However, 
injection of the HSV-1 vectors into the inferior olivary complex 
was shown to result in the transduction of thousands of Purkinje 
cells as well as transduction of deep cerebellar nuclei neurons 
as described in an earlier section (Fig. 4B).13 The authors of 
that study speculated that HSV-1 in the inferior olivary complex 
was initially delivered to the cerebellar nuclei neurons by 
axonal transport. In the deep cerebellar nuclei, the virus went 
over the synaptic cleft to axon terminals of Purkinje cells and 
was transported retrogradely to the soma of Purkinje cells 
through their axons.  
Both rAAV vectors23 and lentiviral vectors27 injected into 
the cerebellar cortex transduced cells in the cerebellar cortex, 
but not neurons in the pontine nuclei or inferior olivary nuclei 
(Fig. 4C, D). Interestingly, neurons in the deep cerebellar 
nuclei were transduced by rAAV vectors (Fig. 4C), but not by 
lentiviral vectors (Fig. 4D). This finding is puzzling because 
rAAV vectors are not transported transsynaptically. One 
possible and simple explanation to account for this observation 
is that the rAAV particles injected into the cerebellar cortex 
spread over the deep cerebellar nuclei. More careful studies 




It has been a big challenge to achieve efficient gene transfer 
into Purkinje cells in vivo. Recent progress in viral vector 
development, however, has allowed us to accomplish this to a 
certain extent, although the transduction efficiency and 
reproducibility in gene-modified mice generated by 
developmental engineering are still superior to those achieved 
using viral vectors. One promising application of viral vectors 
is rescue of a gene in a knock-out mouse, followed by evaluation 
of the functional recovery as shown in our recent report.31 Most 
genes are expressed in variety of tissues or cell types, and 
therefore even if a simple knock-out of a gene leads to some 
abnormal phenotype, it is difficult to determine the region or 
cell type responsible for the abnormal phenotype. Thus, 
viral-vector-mediated rescue of a defective gene at a specific 
site or in a specific cell type in a knock-out mouse is a powerful 
means to dissect the roles of a gene of unknown function in 
various regions. Furthermore, viral vectors enable us to 
express various types of mutant genes such as a mutant lacking 
a phosphorylation site, a glycosylation site or a domain 
interacting with particular signaling molecules. Subsequent 
functional assays of the transduced cells could provide useful 
information about the signals mediated by the modified gene 
product. Viral-vector-mediated gene transfer to Purkinje cells 
in vivo will be a major approach in the near future for exploring 
cerebellar function and therapeutic targeting of disorders that 
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Transduction of Purkinje cells in vivo using rAAV vector. rAAV 
vector expressing GFP was injected into the cerebellar cortex. 
Cerebellar sections were made 7 days after the viral injection. 
Scale bar, 50 µm.  
 
Fig. 2 
Striking decrease in the lentiviral tropism for Purkinje cells 
upon prolonged cultivation of HEK293FT cells. HEK293 cells were 
transfected with lentiviral plasmid carrying the GFP gene. (A, 
C) GFP fluorescence images overlaid on the phase contrast images 
of HEK293FT cells 40 h (A) and 64 h (C) after transfection. Note 
that a substantial number of HEK293FT cells were detached from 
the dish surface 64 h after transfection. The viral solutions 
prepared from medium 40 h and 64 h after transfection were named 
as 40-h virus and 64-h virus, respectively. The biological titer 
of the 40-h virus stock was almost identical to that of the 64-h 
viral stock (~5 x108 transducing units/ml). (B, D) Confocal GFP 
fluorescence images of a sagittal section of cerebellar vermis 
7 days after 40-h (B) or 64-h (D) virus injection into the 
cerebellar cortex. Note that the 40-h virus transduced mainly 
Purkinje cells (B), whereas the majority of cells transduced 
by the 64-h virus were Bergmann glia. Scale bar, 50 µm.  
 
Fig. 3 
Distinct patterns of transduction in cerebellar cells depending 
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on the batch of lentiviral vectors produced using different lots 
of FBS. Four microliters of lentiviral vectors produced using 
serum from Equitech-Bio (A) or from HyClone Laboratories (B) 
were injected into a mouse cerebellar cortex. Mice were 
sacrificed 7 days after injection. The panels show GFP 
fluorescence of a sagittal section of the cerebellar vermis. 
Lentiviral vectors produced using serum from Equitech-Bio 
showed preferential transduction of neurons (A): those produced 
using serum from HyClone Laboratories transduced mainly glial 
cells (B). Scale bar, 50 µm. 
 
Fig. 4 
Schematic drawing depicting the viral injection site and 
resultant transduced area in the brain. (A) LacZ expression in 
cerebellar cortex, potine nuclei and inferior olivary complex 
upon adenoviral injection into the cerebellar cortex.6 (B) LacZ 
expression in Purkinje cells illustrated as blue dots, deep 
cerebellar nuclei and inferior olivary nuclei upon HSV-1 
injection into the inferior olivary complex.13 (C) LacZ 
expression in cerebellar cortex and deep cerebellar nuclei upon 
adeno-associated-viral injection into the cerebellar cortex.23 
(D) GFP expression confined to the cerebellar cortex upon 
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